THERAPEUTISCHE GLEICHWERTIGKEIT UND UNGLEICHWERTIGKEIT CHEMISCH IDENTISCHER STOFFE (INSBESONDERE AM BEISPIEL DER HERZGLYKOSIDE) = EQUIVALENCE ET NON-EQUIVALENCE THERAPEUTIQUE DE SUBSTANCES CHIMIQUEMENT IDENTIQUES (EXEMPLE PARTICULIER DES GLUCOSIDES CARDIAQUES)RIETBROCK N.1976; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1976; VOL. 26; NO 1A; PP. 135-146; ABS. ANGL.; BIBL. 1 P.Article

COLOR VISION DEFICIENCIES: A COMMON SIGN OF INTOXICATION IN CHRONICALLY DIGOXIN-TREATED PATIENTSRIETBROCK N; ALKEN RG.1980; J. CARDIOVASC. PHARMACOL.; USA; DA. 1980; VOL. 2; NO 1; PP. 93-99; BIBL. 16 REF.Article

PRAEOPERATIVE DIGITALISIERUNG. BESTIMMUNG DER DIGOXINSPIEGEL IM PLASMA. = DIGITALISATION PREOPERATOIRE. DETERMINATION DU TAUX DE DIGOXINE DANS LE PLASMAGEIGER HJ; RIETBROCK N.1976; ANAESTHESIST; DTSCH.; DA. 1976; VOL. 25; NO 9; PP. 405-417; ABS. ANGL.; BIBL. 46 REF.Article

STOPPED-FLOW STUDIES ON DRUG-PROTEIN BINDING. I: KINETICS OF WARFARIN BINDING TO HUMAN SERUM ALBUMINRIETBROCK N; LASSMANN A.1980; NAUNYN-SCHMIEDEBERG ARCH. PHARMACOL.; ISSN 0369-5565; DEU; DA. 1980; VOL. 313; NO 3; PP. 269-274; BIBL. 13 REF.Article

RELATIONSHIP BETWEEN DOSE AND PLASMA LEVEL OF DIGOXIN AND PATIENT CHARACTERISTICSHEINZ N; RIETBROCK N.1979; EUROP. J. CLIN. PHARMACOL.; DEU; DA. 1979; VOL. 15; NO 2; PP. 109-114; BIBL. 33 REF.Article

WECHSELWIRKUNGEN BEI DER ANTIINFEKTIOESEN THERAPIE. = EFFETS SECONDAIRES DES ANTIINFECTIEUXKUHLMANN J; RIETBROCK N.1975; DTSCHE MED. WSCHR.; DTSCH.; DA. 1975; VOL. 100; NO 48; PP. 2496-2505; BIBL. 110 REF.Article

METABOLISM AND EXCRETION OF ³H-DIGITOXIN IN THE RAT = LE METABOLISME ET L'EXCRETION DE LA DIGITOXINE-³H CHEZ LE RATRIETBROCK N; VOHRINGER HF.1974; BIOCHEM. PHARMACOL.; G.B.; DA. 1974; VOL. 23; NO 18; PP. 2567-2575; BIBL. 21REF.Article

METABOLISM AND EXCRETION OF DIGITOXIN IN MAN = METABOLISME ET EXCRETION DE LA DIGITOXINE CHEZ L'HOMMEVOHRINGER HF; RIETBROCK N.1974; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1974; VOL. 16; NO 5 PART. 1; PP. 796-806; BIBL. 25REF.Article

DIE THERAPIE DER HERZINSUFFIZIENZ MIT DIGITALIS = LE TRAITEMENT DE L'INSUFFISANCE CARDIAQUE PAR LES DIGITALIQUESRIETBROCK N; ALKEN RG.1980; DTSCH. MED. WOCHENSCHR.; ISSN 0012-0472; DEU; DA. 1980; VOL. 105; NO 46; PP. 1622-1628; BIBL. 30 REF.Article

METABOLISM AND EXCRETION OF METHYLPROSCILLARIDIN BY MAN. = METABOLISME ET EXCRETION DE LA METHYLPROSCILLARIDINE CHEZ L'HOMMERIETBROCK N; STAUD R.1975; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1975; VOL. 8; NO 6; PP. 427-432; BIBL. 16 REF.Article

GERINNUNGSPHYSIOLOGISCHE AKTIVITAET VON 2-ARYL-2,3,4,5-TETRAHYDRO-1H-BENZOCYCLOHEPTEN-1,3-DIONEN. = ACTIVITE ANTICOAGULANTE DES ARYL-2 TETRAHYDRO-2,3,4,5 1H-BENZOCYCLOHEPTENE DIONES-1,3REHSE K; LANG T; RIETBROCK N et al.1977; ARCH. PHARM.; DTSCH.; DA. 1977; VOL. 310; NO 12; PP. 979-987; ABS. ANGL.Article

PHARMACOKINETICS AND METABOLISM OF DIGOXIN-AND BETA -METHYL-DIGOXIN-12ALPHA -³H IN PATIENTS WITH ACUTE HEPATITIS = PHARMACOCINETIQUE ET METABOLISME DE LA DIGOXINE- ET DE LA BETA-METHYL-DIGOXINE-12ALPHA-³H CHEZ DES MALADES ATTEINTS D'HEPATITE AIGUEZILLY W; RICHTER E; RIETBROCK N et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 17; NO 3; PP. 302-309; BIBL. 8REF.Article

THE INFLUENCE OF INTRAVENOUS CANRENOATE ON THE DETERMINATION OF DIGOXIN IN SERUM BY RADIO- AND ENZYME-IMMUNOASSAYLICHEY J; RIETBROCK N; BORNER K et al.1979; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; DEU; DA. 1979; VOL. 17; NO 2; PP. 61-63; BIBL. 7 REF.Article

VERGLEICHENDE UNTERSUCHUNG DER ABSOLUTEN BIOVERFUEGBARKEIT VON VIER ORALEN DIGOXIN-PRAEPARATEN = RECHERCHES COMPAREES SUR LA BIODISPONIBILITE ABSOLUE DE 4 PREPARATIONS ORALES DE DIGOXINERIETBROCK N; ALKEN RG; EBERT W et al.1979; ARZNEIMITTEL-FORSCH.; DEU; DA. 1979; VOL. 29; NO 11; PP. 1742-1745; ABS. ENG; BIBL. 19 REF.Article

CYTOSTATIC DRUGS ARE WITHOUT SIGNIFICANT EFFECT ON DIGITOXIN PLASMA LEVEL AND RENAL EXCRETIONKUHLMANN J; WILKE J; RIETBROCK N et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 5; PP. 646-651; BIBL. 34 REF.Article

DER EINFLUSS VON ETHANOL AUF DIE IN-VITRO UND IN-VIVO FREISETZUNG VON DIGOXIN AUS TABLETTENPRAEPARATEN = INFLUENCE DE L'ETHANOL SUR LA LIBERATION IN VITRO ET IN VIVO DE LA DIGOXINE, A PARTIR DE COMPRIMESSCHWABE L; RIETBROCK N; FROEMMING KH et al.1979; PHARM. INDUSTR.; DEU; DA. 1979; VOL. 41; NO 12; PP. 1207-1212; ABS. ENG; BIBL. 16 REF.Article

DIE BIOLOGISCHE VERFUEGBARKEIT VON DIGITOXIN. = LA DISPONIBILITE BIOLOGIQUE DE LA DIGITOXINEVOEHRINGER HF; LEOPOLD G; RIETBROCK N et al.1978; FORTSCHR. D. MED.; DTSCH.; DA. 1978; VOL. 96; NO 2; PP. 71Article

DIE BIOLOGISCHE VERFUEGBARKEIT VON DIGITOXIN. = LA DISPONIBILITE BIOLOGIQUE DE LA DIGITOXINEVOHRINGER HF; WOGENSTEIN HM; RIETBROCK N et al.1977; FORTSCHR. D. MED.; DTSCH.; DA. 1977; VOL. 95; NO 38; PP. 2323-2331 (7P.); ABS. ANGL.; BIBL. 32 REF.Article

EXCRETION OF METHYLPROSCILLARIDIN IN PATIENTS WITH A BILIARY FISTULA.STAUD R; RIETBROCK N; FASSBENDER HP et al.1975; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1975; VOL. 9; NO 2-3; PP. 99-103; BIBL. 8 REF.Article

DIRECT DETERMINATION OF HEPATIC OF VERAPAMIL IN CARDIAC PATIENTSWOODCOCK BG; SCHULZ W; KOBER G et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 30; NO 1; PP. 52-56; BIBL. 9 REF.Article

VERAPAMIL DISPOSTION IN LIVER DISEASE AND INTENSIVE-CARE PATIENTS: KINETICS, CLEARANCE, AND APPARENT BLOOD FLOW RELATIONSHIPSWOODCOCK BG; RIETBROCK I; VOEHRINGER HF et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 29; NO 1; PP. 27-34; BIBL. 19 REF.Article

FORMATION AND DISPOSITION OF BIS-AND MONOGLYCOSIDES AFTER ADMINISTRATION OF ³H-4PRIME PRIME PRIME -METHYLDIGOXIN TO MAN = FORMATION ET REPARTITION DES BIS- ET MONOGLUCOSIDES APRES ADMINISTRATION DE METHYL-4PRIME PRIME PRIME -DIGITOXINE (12-³H) A L'HOMMEABSHAGEN U; RENNEKAMP H; KUECHLER R et al.1974; EUROP. J. CLIN. PHARMACOL.; GERM.; DA. 1974; VOL. 7; NO 3; PP. 177-181; BIBL. 22REF.Article

Oxygen release kinetics in healthy subjects and diabetic patients. II: Effects of HbCOMARSCHNER, J.-P; RIETBROCK, N.International journal of clinical pharmacology and therapeutics. 1995, Vol 33, Num 5, pp 263-265, issn 0946-1965Article

Oxygen release kinetics in healthy subjects and diabetic patients. I: The role of 2,3-diphosphoglycerateMARSCHNER, J.-P; RIETBROCK, N.International journal of clinical pharmacology and therapeutics. 1994, Vol 32, Num 10, pp 533-535, issn 0946-1965Article

DIFFERENCES IN COLOR VISION IMPAIRMENT CAUSED BY DIGOXIN, DIGITOXIN, OR PENGITOXINHAUSTEIN KO; OLTMANNS G; RIETBROCK N et al.1982; J. CARDIOVASC. PHARMACOL.; ISSN 0160-2446; USA; DA. 1982; VOL. 4; NO 4; PP. 536-541; BIBL. 28 REF.Article